MD970244A - Noi aplicatii ale dimerului lizozimei - Google Patents

Noi aplicatii ale dimerului lizozimei

Info

Publication number
MD970244A
MD970244A MD97-0244A MD970244A MD970244A MD 970244 A MD970244 A MD 970244A MD 970244 A MD970244 A MD 970244A MD 970244 A MD970244 A MD 970244A
Authority
MD
Moldova
Prior art keywords
dimer
new application
lysozime
compositions
new
Prior art date
Application number
MD97-0244A
Other languages
English (en)
Other versions
MD1633B2 (ro
MD1633C2 (ro
Inventor
Witold Pl Kiczka
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of MD970244A publication Critical patent/MD970244A/ro
Publication of MD1633B2 publication Critical patent/MD1633B2/ro
Publication of MD1633C2 publication Critical patent/MD1633C2/ro

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Fish Paste Products (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MD97-0244A 1995-01-13 1996-01-13 Aplicare a dimerului lizozimei şi metodă de stimulare nespecifică celulară şi umorală a mecanismelor de protecţie a sistemului imun şi metodă de profilaxie sau tratament al stării imunodepresive sau maladiilor legate de ea MD1633C2 (ro)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95100446 1995-01-13
EP95110638 1995-07-07
PCT/EP1996/000135 WO1996021463A2 (en) 1995-01-13 1996-01-13 New applications of lysozyme dimer

Publications (3)

Publication Number Publication Date
MD970244A true MD970244A (ro) 1999-05-31
MD1633B2 MD1633B2 (ro) 2001-03-31
MD1633C2 MD1633C2 (ro) 2001-10-31

Family

ID=26138401

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0244A MD1633C2 (ro) 1995-01-13 1996-01-13 Aplicare a dimerului lizozimei şi metodă de stimulare nespecifică celulară şi umorală a mecanismelor de protecţie a sistemului imun şi metodă de profilaxie sau tratament al stării imunodepresive sau maladiilor legate de ea

Country Status (37)

Country Link
EP (2) EP1086703A3 (ro)
JP (1) JPH10511974A (ro)
KR (1) KR100420377B1 (ro)
CN (1) CN1090506C (ro)
AP (2) AP628A (ro)
AT (1) ATE218367T1 (ro)
AU (1) AU709620B2 (ro)
BA (1) BA96074A (ro)
BG (1) BG62239B1 (ro)
BR (1) BR9606973A (ro)
CA (1) CA2210091A1 (ro)
CZ (1) CZ293353B6 (ro)
DE (2) DE69621589D1 (ro)
DZ (1) DZ1964A1 (ro)
EA (1) EA001462B1 (ro)
EE (1) EE9700154A (ro)
ES (1) ES2109208T1 (ro)
FI (1) FI972943L (ro)
GB (1) GB2311724B (ro)
GE (1) GEP20012571B (ro)
GR (1) GR970300047T1 (ro)
HR (1) HRP960014A2 (ro)
HU (1) HU223903B1 (ro)
IL (1) IL116737A (ro)
MA (1) MA23775A1 (ro)
MD (1) MD1633C2 (ro)
MY (1) MY132437A (ro)
NO (1) NO973203D0 (ro)
NZ (1) NZ298432A (ro)
OA (1) OA10436A (ro)
PL (1) PL185678B1 (ro)
SK (1) SK94297A3 (ro)
SV (1) SV1996000001A (ro)
TN (1) TNSN96004A1 (ro)
TR (1) TR199700633T1 (ro)
UA (1) UA50728C2 (ro)
WO (1) WO1996021463A2 (ro)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
ATE211389T1 (de) * 1998-04-27 2002-01-15 Nika Health Products Ltd Zusammensetzung zur verbesserung der fruchtbarkeit und ihre verwendung
AUPP489798A0 (en) * 1998-07-28 1998-08-20 Mediko Pty Ltd Hair growth/maintenance compositions and methods
EP2134354A4 (en) * 2007-03-02 2012-03-21 Saint Simeon Lda COMPOSITION AND METHOD FOR THE TREATMENT OF PAPILLOMA VIRUS AND HORSE SARCODES
CN103518978B (zh) * 2013-10-22 2016-01-13 上海艾魁英生物科技有限公司 新型溶菌酶制剂及其制备方法
CN105828829A (zh) * 2013-12-18 2016-08-03 帝斯曼知识产权资产管理有限公司 用于含角蛋白的组织的包含溶菌酶水解物的组合物
CN104585546B (zh) * 2015-01-20 2019-02-05 上海海洋大学 一种促生长抗应激罗非鱼饲料及其制备方法
CN105707509B (zh) * 2016-01-25 2018-12-28 浙江艾杰斯生物科技有限公司 一种用于防治草鱼烂腮病的饲料添加剂
WO2020099556A1 (en) 2018-11-14 2020-05-22 Universiteit Antwerpen Oxidized lysozyme
EP4003300A4 (en) * 2019-07-26 2023-06-28 Infinant Health, Inc Nutritive compositions with bioactive proteins
CN111657407A (zh) * 2020-05-14 2020-09-15 上海艾魁英生物科技有限公司 提高断奶仔猪非特异性免疫功能的饲料添加剂、其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533408A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Immunity-increasing agent
JPS5543040A (en) * 1978-09-25 1980-03-26 Eisai Co Ltd Immunity raising agent
DE3230999A1 (de) * 1982-08-20 1984-02-23 Philips Kommunikations Industrie AG, 8500 Nürnberg Verfahren zur zugriffssteuerung bei einem nachrichtensystem
EP0181634A3 (en) * 1984-11-14 1987-09-09 Takeda Chemical Industries, Ltd. Synthetic gene for human lysozyme
RU2061496C1 (ru) * 1985-08-02 1996-06-10 Институт общей патологии и экологии человека Средство, стимулирующее эритропоэз
JPH01501939A (ja) * 1987-01-28 1989-07-06 オーソ・フアーマシユーチカル・コーポレーシヨン 免疫抑制ペプチドおよび使用法
US5200182A (en) * 1988-05-26 1993-04-06 Nika Health Products, Ltd. Antiviral or antibacterial composition and method of use
AU645252B2 (en) * 1990-01-08 1994-01-13 Nika Health Products Ltd. Method of producing ribonuclease dimers
CA2073351C (en) * 1990-01-08 2001-10-16 Nika Health Products, Inc. Lysozyme dimers and method of preparing them
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
RU2082413C1 (ru) * 1993-06-30 1997-06-27 Нижегородский государственный медицинский институт Способ лечения язвенной болезни двенадцатиперстной кишки
RU2071339C1 (ru) * 1994-07-25 1997-01-10 Щербакова Элеонора Григорьевна Средство для лечения и профилактики дисбактериоза
RU2123345C1 (ru) * 1997-07-31 1998-12-20 Научно-исследовательский институт детского питания Российской Академии сельскохозяйственных наук Средство для лечения дисбактериоза

Also Published As

Publication number Publication date
MA23775A1 (fr) 1996-10-01
EE9700154A (et) 1997-12-15
DZ1964A1 (fr) 2002-10-15
CA2210091A1 (en) 1996-07-18
HUP9801689A2 (hu) 1998-10-28
HUP9801689A3 (en) 2000-07-28
UA50728C2 (uk) 2002-11-15
ATE218367T1 (de) 2002-06-15
EA199700101A1 (ru) 1997-12-30
CN1090506C (zh) 2002-09-11
NO973203L (no) 1997-07-10
EP1086703A2 (en) 2001-03-28
IL116737A (en) 2000-02-17
EP0804227A2 (en) 1997-11-05
WO1996021463A3 (en) 1996-09-19
EA001462B1 (ru) 2001-04-23
FI972943A7 (fi) 1997-07-11
MD1633B2 (ro) 2001-03-31
AP871A (en) 2000-09-10
CZ220297A3 (cs) 1998-02-18
HU223903B1 (hu) 2005-03-29
GB9714354D0 (en) 1997-09-10
OA10436A (en) 2001-12-07
GB2311724B (en) 1999-07-21
NO973203D0 (no) 1997-07-10
MD1633C2 (ro) 2001-10-31
GB2311724A (en) 1997-10-08
MY132437A (en) 2007-10-31
BG62239B1 (bg) 1999-06-30
NZ298432A (en) 2001-03-30
GEP20012571B (en) 2001-11-26
JPH10511974A (ja) 1998-11-17
AP628A (en) 1998-02-27
PL321546A1 (en) 1997-12-08
SK94297A3 (en) 1998-01-14
BR9606973A (pt) 1999-01-26
EP0804227B1 (en) 2002-06-05
DE69621589D1 (de) 2002-07-11
FI972943A0 (fi) 1997-07-11
GR970300047T1 (en) 1997-12-31
CZ293353B6 (cs) 2004-04-14
HRP960014A2 (en) 1997-12-31
AP9600783A0 (en) 1996-04-30
CN1177303A (zh) 1998-03-25
PL185678B1 (pl) 2003-07-31
DE804227T1 (de) 1998-04-09
KR100420377B1 (ko) 2004-05-20
FI972943L (fi) 1997-07-11
TR199700633T1 (xx) 1998-01-21
SV1996000001A (es) 1997-02-17
KR19980701337A (ko) 1998-05-15
BA96074A (bs) 1999-08-02
AU4391696A (en) 1996-07-31
WO1996021463A2 (en) 1996-07-18
ES2109208T1 (es) 1998-01-16
AU709620B2 (en) 1999-09-02
BG101709A (en) 1998-03-31
IL116737A0 (en) 1996-05-14
EP1086703A3 (en) 2001-05-02
HK1002060A1 (en) 1998-07-31
TNSN96004A1 (fr) 2005-03-15
AP9701024A0 (en) 1997-07-31

Similar Documents

Publication Publication Date Title
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
ZA943744B (en) Therapeutic substituted guanidines
HU9603251D0 (en) Lactobacillus strains of human origin, their compositions and uses thereof
EA200000718A1 (ru) Композиции целекоксиба
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
AR243381A1 (es) Procedimiento de obtencion de una composicion farmaceutica para la prevencion de enfermedades que se pueden transmitir por via sexual.
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
EP0975351A4 (en) TREATMENT OF MULTIPLE Sclerosis BY TAKING OR INHALING COPOLYMER-1
MX9701385A (es) Preparacion de producto combinado para usarse en enfermedades inmunologicas.
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
MY110014A (en) Psyllium-containing products.
WO1996022305A3 (en) Modified peptides
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
BG105275A (en) Tan-1057 derivatives
MD1633C2 (ro) Aplicare a dimerului lizozimei şi metodă de stimulare nespecifică celulară şi umorală a mecanismelor de protecţie a sistemului imun şi metodă de profilaxie sau tratament al stării imunodepresive sau maladiilor legate de ea
MX9702926A (es) L-eritrosilnucleosidos.
FR2651435B1 (ro)
BG102667A (en) Diosgenine-containing composition
IL105276A (en) (S)-a-PHENYL- 2-PYRIDINEETHANAMINE, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
LT96093A (en) The active ingredient of pharmaceutical composition for treating aphtae and stomatitis
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
BG103512A (en) Substituted pyramidine compounds and their application

Legal Events

Date Code Title Description
PD99 Pending application